Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale.
Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale.
复制标题
DOI：
10.1188/11.onf.e46-e54
复制
发表时间：
2011-01
影响因子：
1.9
通讯作者：
Hwang WJ
中科院分区：
文献类型：
--
作者：
Cataldo JK;Slaughter R;Jahan TM;Pongquan VL;Hwang WJ
开发一种基于HIV污名量表的测量肺癌患者污名感的工具。心理分析。在线调查。186例肺癌患者。一个探索性的因素分析与共同因素模型使用α因素提取。肺癌的污名、抑郁和生活质量。出现了四个因素：耻辱和羞耻、社会孤立、歧视和吸烟。检查未旋转的第一因子负载显示支持一般柱头因子。构念效度受自尊、抑郁、社会支持和社会冲突等相关构念的影响。子量表的alpha系数范围为0.75 - 0.97（污名和羞耻感为0.96，社会隔离为0.97，歧视为0.9，吸烟为0.75），43项Cataldo肺癌污名量表（CLCSS）的alpha系数为0.98，提供了可靠性证据。CLCSS的最终版本有31个项目。重新计算总病耻感量表（0.96）和4个子量表（病耻感和羞耻感量表0.97、社会孤立量表0.96、歧视量表0.92、吸烟量表0.75）的alpha系数。在该肺癌患者样本中，CLCSS是一种可靠和有效的与健康相关的耻辱感测量方法。CLCSS可用于识别肺癌耻辱感的存在和影响，并允许为肺癌患者制定有效的耻辱感干预措施。
To develop an instrument to measure the stigma perceived by people with lung cancer based on the HIV Stigma Scale. Psychometric analysis. Online survey. 186 patients with lung cancer. An exploratory factor analysis with a common factor model using alpha factor extraction. Lung cancer stigma, depression, and quality of life. Four factors emerged: stigma and shame, social isolation, discrimination, and smoking. Inspection of un-rotated first-factor loadings showed support for a general stigma factor. Construct validity was supported by relationships with related constructs: self-esteem, depression, social support, and social conflict. Coefficient alphas ranging from 0.75–0.97 for the subscales (0.96 for stigma and shame, 0.97 for social isolation, 0.9 for discrimination, and 0.75 for smoking) and 0.98 for the 43-item Cataldo Lung Cancer Stigma Scale (CLCSS) provided evidence of reliability. The final version of the CLCSS was 31 items. Coefficient alpha was recalculated for the total stigma scale (0.96) and the four subscales (0.97 for stigma and shame, 0.96 for social isolation, 0.92 for discrimination, and 0.75 for smoking). The CLCSS is a reliable and valid measure of health-related stigma in this sample of people with lung cancer. The CLCSS can be used to identify the presence and impact of lung cancer stigma and allow for the development of effective stigma interventions for patients with lung cancer.